Evidence map›Paper›PMID 32778786›Full record

ArticleScientific reports2020

Analysis of Wilson disease mutations revealed that interactions between different ATP7B mutants modify their properties.

Shubhrajit Roy, Courtney J McCann, Martina Ralle, Kunal Ray, Jharna Ray, Svetlana Lutsenko, Samuel Jayakanthan

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Monoallelic ATP7B variants in adult-onset cerebellar ataxia.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Missing heritability of Wilson disease: a search for the uncharacterized mutations.Mammalian genome : official journal of the International Mammalian Genome Society · 2023
    Review
  14. Article
  15. Novel mutations inFrontiers in neurology · 2023
    Article
  16. Article
  17. Review
  18. Article
  19. Estimating the clinical prevalence of Wilson's disease in the UK.JHEP reports : innovation in hepatology · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Shubhrajit RoyDepartment of Physiology, Johns Hopkins Medical Institute, Baltimore, MD, USA. shubhrajitroy123@gmail.com.
Courtney J McCannDepartment of Physiology, Johns Hopkins Medical Institute, Baltimore, MD, USA.
Martina RalleOregon Health and Science University, Portland, OR, USA.
Kunal RayATGC Diagnostics Private Ltd, Kolkata, India.
Jharna RayS. N. Pradhan Centre for Neurosciences, University of Calcutta, Kolkata, India.
Svetlana Lutsenko *Department of Physiology, Johns Hopkins Medical Institute, Baltimore, MD, USA. lutsenko@jhmi.edu.
Samuel Jayakanthan *Department of Physiology, Johns Hopkins Medical Institute, Baltimore, MD, USA.
Oregon Health & Science University · USUniversity of Calcutta · IN

Funding

Integrative Analysis of Wilson's DiseaseR01GM101502 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI LUTSENKO, SVETLANA · 2012 to 2021
$3.6M
ICP-MS to Measure Elemental ConcentrationsS10RR025512 · NCRR · OREGON HEALTH & SCIENCE UNIVERSITY · PI RALLE, MARTINA · 2009 to 2009
$168k
NCRR NIH HHS S10 RR025512NIGMS NIH HHS R01 GM101502
6 · The paper itself

Abstract

Wilson disease (WD) is an autosomal-recessive disorder caused by mutations in the copper (Cu)-transporter ATP7B. Thus far, studies of WD mutations have been limited to analysis of ATP7B mutants in the homozygous states. However, the majority of WD patients are compound-heterozygous, and how different mutations on two alleles impact ATP7B properties is unclear. We characterized five mutations identified in Indian WD patients, first by expressing each alone and then by co-expressing two mutants with dissimilar properties. Mutations located in the regulatory domains of ATP7B-A595T, S1362A, and S1426I-do not affect ATP7B targeting to the trans-Golgi network (TGN) but reduce its Cu-transport activity. The S1362A mutation also inhibits Cu-dependent trafficking from the TGN. The G1061E and G1101R mutations, which are located within the ATP-binding domain, cause ATP7B retention in the endoplasmic reticulum, inhibit Cu-transport, and lower ATP7B protein abundance. Co-expression of the A595T and G1061E mutations, which mimics the compound-heterozygous state of some WD patients, revealed an interaction between these mutants that altered their intracellular localization and trafficking under both low and high Cu conditions. These findings highlight the need to study WD variants in both the homozygous and compound-heterozygous states to better understand the genotype-phenotype correlations and incomplete penetrance observed in WD.

Indexed as

Adenosine TriphosphatasesAllelesCation Transport ProteinsCopperCopper-Transporting ATPasesEndoplasmic ReticulumGenetic Association StudiesHEK293 CellsHepatolenticular DegenerationHumansMutationProtein Transporttrans-Golgi NetworkAdenosine TriphosphatasesATP7B protein, humanCation Transport ProteinsCopperCopper-Transporting ATPases

Identifiers

PMID32778786
PMCPMC7418023
OpenAlexW3047989378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.